Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA.
Hirsch TZ, Negulescu A, Gupta B, Caruso S, Noblet B, Couchy G, Bayard Q, Meunier L, Morcrette G, Scoazec JY, Blanc JF, Amaddeo G, Nault JC, Bioulac-Sage P, Ziol M, Beaufrère A, Paradis V, Calderaro J, Imbeaud S, Zucman-Rossi J. Hirsch TZ, et al. Among authors: beaufrere a. J Hepatol. 2020 May;72(5):924-936. doi: 10.1016/j.jhep.2019.12.006. Epub 2019 Dec 18. J Hepatol. 2020. PMID: 31862487 Free article.
Corrigendum to: "BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA" [J Hepatol (2020) 1-13].
Hirsch TZ, Negulescu A, Gupta B, Caruso S, Noblet B, Couchy G, Bayard Q, Meunier L, Morcrette G, Scoazec JY, Blanc JF, Amaddeo G, Nault JC, Bioulac-Sage P, Ziol M, Beaufrère A, Paradis V, Calderaro J, Imbeaud S, Zucman-Rossi J. Hirsch TZ, et al. Among authors: beaufrere a. J Hepatol. 2020 Jul;73(1):225-226. doi: 10.1016/j.jhep.2020.04.004. Epub 2020 Apr 29. J Hepatol. 2020. PMID: 32360197 No abstract available.
Combined hepatocellular-cholangiocarcinoma: An update.
Beaufrère A, Calderaro J, Paradis V. Beaufrère A, et al. J Hepatol. 2021 May;74(5):1212-1224. doi: 10.1016/j.jhep.2021.01.035. Epub 2021 Feb 3. J Hepatol. 2021. PMID: 33545267 Review.
Enhancing capsule in hepatocellular carcinoma: intra-individual comparison between CT and MRI with extracellular contrast agent.
Cannella R, Ronot M, Sartoris R, Cauchy F, Hobeika C, Beaufrere A, Trapani L, Paradis V, Bouattour M, Bonvalet F, Vilgrain V, Dioguardi Burgio M. Cannella R, et al. Among authors: beaufrere a. Diagn Interv Imaging. 2021 Dec;102(12):735-742. doi: 10.1016/j.diii.2021.06.004. Epub 2021 Jul 18. Diagn Interv Imaging. 2021. PMID: 34284951 Free article.
Immune Profiling of Combined Hepatocellular- Cholangiocarcinoma Reveals Distinct Subtypes and Activation of Gene Signatures Predictive of Response to Immunotherapy.
Nguyen CT, Caruso S, Maille P, Beaufrère A, Augustin J, Favre L, Pujals A, Boulagnon-Rombi C, Rhaiem R, Amaddeo G, di Tommaso L, Luciani A, Regnault H, Brustia R, Scatton O, Charlotte F, Brochériou I, Sommacale D, Soussan P, Leroy V, Laurent A, Le VK, Ta VT, Trinh HS, Tran TL, Gentien D, Rapinat A, Nault JC, Allaire M, Mulé S, Zucman-Rossi J, Pawlotsky JM, Tournigand C, Lafdil F, Paradis V, Calderaro J. Nguyen CT, et al. Among authors: beaufrere a. Clin Cancer Res. 2022 Feb 1;28(3):540-551. doi: 10.1158/1078-0432.CCR-21-1219. Epub 2021 Nov 16. Clin Cancer Res. 2022. PMID: 34785581
86 results